{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T05:11:09Z","timestamp":1787461869802,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.semdp.2011.07.004","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T18:59:27Z","timestamp":1327777167000},"page":"2-11","source":"Crossref","is-referenced-by-count":19,"title":["Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia"],"prefix":"10.1053","volume":"29","author":[{"given":"Stephanie","family":"McGregor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gurbuxani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2011.07.004_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":"Biology, risk stratification, and therapy of pediatric acute leukemias: an update","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V65.5.1079.1079","article-title":"Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia","volume":"65","author":"Look","year":"1985","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","article-title":"Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study","volume":"10","author":"Trueworthy","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib6","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood.V79.12.3316.bloodjournal79123316","article-title":"Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study","volume":"79","author":"Harris","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403673","volume":"19","author":"Sutcliffe","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2000.18.9.1876","article-title":"Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)","volume":"18","author":"Heerema","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","article-title":"Incidence and clinical relevance of TEL\/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials","volume":"90","author":"Borkhardt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib10","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","article-title":"TEL\/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia","volume":"88","author":"McLean","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","article-title":"TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance","volume":"15","author":"Rubnitz","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib12","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2141.1997.3493163.x","article-title":"Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X","volume":"99","author":"Chessels","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.004_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","article-title":"Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia","volume":"110","author":"Nachman","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.2010.08314.x","article-title":"Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankf\u00fcrt-M\u00fcnster study group","volume":"151","author":"Harrison","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.004_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Aric\u00f2","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.004_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909093730","article-title":"Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy","volume":"33","author":"Uckun","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.004_bib18","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","article-title":"Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study","volume":"76","author":"Crist","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","article-title":"Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)","volume":"8","author":"Raimondi","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","article-title":"Prognostic impact of t(1;19)\/TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-M\u00fcnster-based protocols","volume":"52","author":"Felice","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.07.004_bib22","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.leu.2403140","article-title":"Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome","volume":"17","author":"Robinson","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib23","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","article-title":"Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib24","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1200\/JCO.2008.16.1117","volume":"26","author":"Attarbaschi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211","article-title":"Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis","volume":"87","author":"Hunger","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib27","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation-2010.1.7","article-title":"Minimal residual disease in acute lymphoblastic leukemia","volume":"2010","author":"Campana","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Programs"},{"key":"10.1053\/j.semdp.2011.07.004_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.07.004_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.004_bib33","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.07.004_bib34","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2011.07.004_bib35","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib36","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.leu.2404948","article-title":"JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials","volume":"22","author":"Pardanani","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib38","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.004_bib40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2009.020792","article-title":"The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome","volume":"95","author":"Iacobucci","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.004_bib41","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2401555","article-title":"Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL","volume":"13","author":"Pullen","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V82.2.343.343","article-title":"Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia","volume":"82","author":"Pui","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib43","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1200\/JCO.1997.15.6.2214","article-title":"Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study","volume":"15","author":"Uckun","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.leu.2404957","article-title":"Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences","volume":"22","author":"van Grotel","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","article-title":"Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951","volume":"103","author":"Cav\u00e9","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2011.07.004_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(04)15542-6","article-title":"Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia","volume":"363","author":"Ferrando","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2011.07.004_bib48","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1476-4598-9-105","article-title":"Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"9","author":"Cleaver","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.semdp.2011.07.004_bib50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"10.1053\/j.semdp.2011.07.004_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1099-1069(199909)17:3<91::AID-HON643>3.0.CO;2-Y","article-title":"Cytogenetics and molecular genetics of childhood leukemia","volume":"17","author":"Ma","year":"1999","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1053\/j.semdp.2011.07.004_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/cc.7.8.5753","article-title":"The role of the PTEN\/AKT pathway in NOTCH1-induced leukemia","volume":"7","author":"Palomero","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1053\/j.semdp.2011.07.004_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/cc.6.4.3858","article-title":"Notches, NFkappaBs and the making of T cell leukemia","volume":"6","author":"Aifantis","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1053\/j.semdp.2011.07.004_bib55","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1038\/onc.2008.222","article-title":"It's T-ALL about Notch","volume":"27","author":"Demarest","year":"2008","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2011.07.004_bib56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"10.1053\/j.semdp.2011.07.004_bib57","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2011.07.004_bib58","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia","volume":"108","author":"Breit","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib60","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","article-title":"The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling","volume":"67","author":"Malyukova","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2011.07.004_bib61","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.2009.07607.x","article-title":"FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma","volume":"145","author":"Park","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.07.004_bib62","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia","volume":"94","author":"Baldus","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.004_bib63","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/leu.2010.204","article-title":"NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols","volume":"24","author":"Zuurbier","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib64","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/leu.2010.205","article-title":"NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951","volume":"24","author":"Clappier","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib65","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol","volume":"27","author":"Mansour","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib66","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/leu.2009.64","article-title":"The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"23","author":"Larson Gedman","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib67","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3816\/CLM.2009.s.013","article-title":"Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia","volume":"3","author":"Palomero","year":"2009","journal-title":"Clin Lymphoma Myeloma 9 suppl"},{"key":"10.1053\/j.semdp.2011.07.004_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1053\/j.semdp.2011.07.004_bib69","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature03659","article-title":"Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.004_bib70","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1535-7163.MCT-10-0034","article-title":"Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design","volume":"9","author":"Wei","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.semdp.2011.07.004_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"10.1053\/j.semdp.2011.07.004_bib72","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/leu.2009.75","article-title":"NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia","volume":"23","author":"Real","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib74","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"Gutierrez","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib75","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1182\/blood-2009-06-227660","article-title":"Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options","volume":"114","author":"Stumpel","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib76","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1158\/1078-0432.CCR-05-2592","article-title":"CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia","volume":"12","author":"Rom\u00e1n-G\u00f3mez","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2011.07.004_bib77","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1200\/JCO.2005.01.4944","article-title":"Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis","volume":"23","author":"Rom\u00e1n-G\u00f3mez","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib78","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","article-title":"Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia","volume":"104","author":"Rom\u00e1n-G\u00f3mez","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib79","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2009-04-214668","article-title":"DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia","volume":"115","author":"Milani","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2011.07.004_bib81","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/leu.2010.282","article-title":"Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale","volume":"25","author":"Stumpel","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.07.004_bib82","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2008.19.3441","article-title":"Epigenetic regulation of microRNAs in acute lymphoblastic leukemia","volume":"27","author":"Rom\u00e1n-G\u00f3mez","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.07.004_bib83","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1182\/blood-2006-09-047043","article-title":"Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia","volume":"109","author":"Rom\u00e1n-G\u00f3mez","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib84","article-title":"The DNA-methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells","author":"Ruiz-Maga\u00f1a","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2011.07.004_bib85","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3324\/haematol.2009.011114","article-title":"Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia","volume":"95","author":"Okamoto","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.07.004_bib86","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1073\/pnas.0800408105","article-title":"Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease","volume":"105","author":"Paulsson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.07.004_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.07.004_bib88","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.07.004_bib89","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"O'Neil","year":"2007","journal-title":"J Exp Med"},{"key":"10.1053\/j.semdp.2011.07.004_bib90","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J Exp Med"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T10:11:40Z","timestamp":1593598300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257011000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0740257011000980"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2011.07.004","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}